Piramal Pharma Proportion Sale: The United States non-public fairness company Carlile Team is making ready to promote as much as 10 p.c stake in India’s Piramal Pharma thru block offers. Moneycontrol has come to understand from assets that thru this proportion sale, Carlile can earn round Rs 2,600-2,700 crore. Carlile purchased a 20 p.c stake in Piramal Pharma for Rs 3,523 crore in June 2020.
Inventory change information displays that via 31 March 2025, Carlile had an 18 p.c stake in Piramal Pharma. On the present marketplace value it sits value Rs 4,836 crore. Funding Financial institution Motilal Oswal has been appointed as a dealer for block trades.
Piramal pharma Stocks climbed 27 p.c in a 12 months
Piramal Pharma’s inventory closed at Rs 202.40 on 3 July on July 3, with a decline of just about 1 p.c. The corporate’s marketplace cap is just about Rs 27000 crore. The face worth of the inventory is Rs 10. The inventory has won 124 p.c in 2 years. It has observed a expansion of 27 p.c in a 12 months. On the identical time, the cost has been 20 p.c inexpensive in 6 months and 12 p.c inexpensive in 3 months. The corporate had a 34.95 p.c stake within the corporate until the tip of March 2025.
In Would possibly, Selection Broking gave a goal value of Rs 235 in line with proportion with a ‘bye’ score for the inventory. Motilal Oswal gave a goal of Rs 250, repeating the ‘bye’ score. Just lately, Goldman Sachs additionally set a goal value of Rs 265 with a ‘bye’ score.
How a lot benefit in March quarter
Piramal Pharma had a income of Rs 1,689.80 crore, web benefit of Rs 277.27 crore and income in line with proportion on Standalone Bay in January-March 2025 quarter. In FY 2024-25, the corporate’s income used to be recorded at Rs 5,285.71 crore, web benefit of Rs 691.40 crore and income in line with proportion of Rs 5.22 crore. The fifth annual common assembly of Piramal Pharma is scheduled to be hung on 30 July 2025.
Document date for dividend 16 July
The corporate goes to present its shareholders a last dividend of Rs 0.14, or 14 paise in line with proportion for FY 2025. The file date for that is 16 July. By way of this date, shareholders whose names will likely be within the data of the Sign in of Participants of the Corporate or Depositors because the beneficiaries house owners of stocks will likely be entitled to dividend. Piramal Pharma gave the general dividend of eleven paise to shareholders for FY 2024.
Disclaimer: Recommendation or thought professionals/brokerage companies given on Moneycontrol.com have their very own non-public perspectives. The web site or control isn’t liable for this. Moneycontrol advises to customers that at all times search the recommendation of qualified professionals ahead of taking any funding choice.